Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective.
about
Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cost-Effectiveness of Insulin ...... anish Health-Care Perspective.
@en
Cost-Effectiveness of Insulin ...... anish Health-Care Perspective.
@nl
type
label
Cost-Effectiveness of Insulin ...... anish Health-Care Perspective.
@en
Cost-Effectiveness of Insulin ...... anish Health-Care Perspective.
@nl
prefLabel
Cost-Effectiveness of Insulin ...... anish Health-Care Perspective.
@en
Cost-Effectiveness of Insulin ...... anish Health-Care Perspective.
@nl
P2093
P2860
P1433
P1476
Cost-Effectiveness of Insulin ...... anish Health-Care Perspective.
@en
P2093
Brian Bekker Hansen
Jens Gundgaard
Marc Evans
P2860
P2888
P304
P356
10.1007/S13300-016-0195-6
P577
2016-08-23T00:00:00Z